RE:Long term contract with Labs Looks like an issue or issues with all companies but no details in the press release to the degree Supreme is involved or if the issue with Supreme is material or not.
The agreement is for the processing of their trim to oil, Supreme is not buying oil or anything else from MediPharm Labs, it is a tolling arangement. Did they not supply the agreed amount for processing?...is there a dispute over services promised and recieved?
Why is there problems with all agreements?
We need more info to determine level of concern for Supreme, if any, and the value of claim involving Supreme, we know it will be less than $9.8mil for sure. In any event it will either be settled by Supreme if just or litigate defense, need more info, JMHO....Opt
MediPharm Labs Files Statement of Claim Ziptrain wrote: Release says private label cannabis oil sales agreement.
MediPharm Labs’ private label program is a high margin business for the Company, whereby it opportunistically procures dry cannabis flower and trim from its thirteen product supply partners, to produce proprietary cannabis oil concentrate products for resale globally on a private label basis.
To date, MediPharm Labs has completed four private label wholesale agreements for cannabis oil concentrate supply (including Canopy Growth Corporation); five long-term cannabis concentrate program (tolling) agreements with James E. Wagner Cultivation Corp., Emerald Health Therapeutics, Inc., INDIVA Limited, The Supreme Cannabis Company, Inc. and TerrAscend Corp.
EMH has a long-term cannabis concentrate program as does Supreme.